Submitted:
23 October 2024
Posted:
23 October 2024
You are already at the latest version
Abstract

Keywords:
1. Introduction
2. Materials and Methods
2.1. Materials
2.2. Granulomeria Protocol
2.3. Microscopy Protocol
Scanning Electron Microscopy (SEM)
Energy-Dispersive X-ray Spectroscopy (EDX)
2.4. Study Design
2.5. MMA Embolization Technique by NAGLEMs
2.6. Analysis of NAGLEMs Behavior During MMA Embolization
- (1)
- Level I is proximal, bounded by the auriculo-orbitalis and supra-orbitalis lines; This level is typically characterised by the origin of the MMA from the maxillary artery and the presence of a large MMA trunk. In accordance with the Adachi classification, as modified by Giuffrida-Ruggeri [46,47,48,49,50], the principal MMA trunk may be subdivided into a frontal and a parietal branch in this region, a characteristic feature of MMA types 2b, 3 and 4. Also at this level, the MMA may have the most dangerous anastamoses with the ophthalmic artery and the tympanic branch of the MMA[2,40,42,51].
- (2)
- Level II is lateral, bounded by the supra-orbitalis and a line through the craniometric Median point; At this level in MMA types 1 and 2a (according to Adachi in the Giuffricla-Ruggeri modification [46,47,48,49,50]), there is a distinction between the main trunk of the MMA, which is divided into frontal and parietal branches. In this region, second- and third-order branches connecting the frontal and parietal branches of the MMA can frequently be observed[2]. Additionally, in this region, the parietal branch often connects to the posterior meningeal artery, which represents a significant anastomosis with the vertebral artery system.
- (3)
- Level III is parasagittal, limited by the line through the craniometric Median point and sagittal plane; At this level, branches are connected with the arteries of the walls of the superior sagittal sinus, and there are direct anastomoses with the anterior circumflex artery and, respectively, with the ophthalmic artery [2].
- (4)
- Level IV – is contralateral for its ipsilateral MMA, Level IV is characterized by collateral connections with the contralateral meningeal arteries and Falx vessels.
2.7. Statistical Analysis
3. Results
3.1. Granulometry
3.2. Microscopy and Energy-Dispersive X-ray Spectroscopy (EDX)
3.3. Patient Population and Analysis of NAGLEMs Behavior During MMA Embolization
3.4. Illustrative Cases
3.4.1. Case #1
3.4.2. Case #2

3.4.3. Case #3
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Petrov, A.; Ivanov, A.; Kolomin, E.; Tukanov, N.; Petrova, A.; Rozhchenko, L.; Suvorova, J. The Advantages of Non-Adhesive Gel-like Embolic Materials in the Endovascular Treatment of Benign Hypervascularized Lesions of the Head and Neck. Gels 2023, 9. [Google Scholar] [CrossRef] [PubMed]
- Shapiro, M.; Walker, M.; Carroll, K.T.; Levitt, M.R.; Raz, E.; Nossek, E.; Delavari, N.; Mir, O.; Nelson, P.K. Neuroanatomy of Cranial Dural Vessels: Implications for Subdural Hematoma Embolization. J Neurointerv Surg 2021, 13, 471–477. [Google Scholar] [CrossRef] [PubMed]
- Petrov, A.; Ivanov, A.; Dryagina, N.; Petrova, A.; Samochernykh, K.; Rozhchenko, L. Angiogenetic Factors in Chronic Subdural Hematoma Development. Diagnostics (Basel) 2022, 12, 2787. [Google Scholar] [CrossRef] [PubMed]
- Petrov, A.; Ivanov, A.; Rozhchenko, L.; Petrova, A.; Bhogal, P.; Cimpoca, A.; Henkes, H. Endovascular Treatment of Chronic Subdural Hematomas through Embolization: A Pilot Study with a Non-Adhesive Liquid Embolic Agent of Minimal Viscosity (Squid). J Clin Med 2021, 10, 564–569. [Google Scholar] [CrossRef] [PubMed]
- Petrov, A.E.; Rozhchenko, L.V.; Ivanov, A.A.; Bobinov, V.V.; Henkes, H. The First Experience of Endovascular Treatment of Chronic Subdural Hematomas with Non-Adhesive Embolization Materials of Various Viscosities: Squid 12 and 18. Voprosy neirokhirurgii imeni N.N. Burdenko 2021, 85, 80. [Google Scholar] [CrossRef]
- Petrov, A.; Kashevnik, A.; Haleev, M.; Ali, A.; Ivanov, A.; Samochernykh, K.; Rozhchenko, L.; Bobinov, V. AI-Based Approach to One-Click Chronic Subdural Hematoma Segmentation Using Computed Tomography Images. Sensors 2024, 24, 721. [Google Scholar] [CrossRef]
- Dian, J.; Linton, J.; Shankar, J.J.S. Risk of Recurrence of Subdural Hematoma after EMMA vs Surgical Drainage – Systematic Review and Meta-Analysis. Interventional Neuroradiology 2021, 27, 577–583. [Google Scholar] [CrossRef]
- Haldrup, M.; Ketharanathan, B.; Debrabant, B.; Schwartz, O.S.; Mikkelsen, R.; Fugleholm, K.; Poulsen, F.R.; Jensen, T.S.R.; Thaarup, L.V.; Bergholt, B. Embolization of the Middle Meningeal Artery in Patients with Chronic Subdural Hematoma-a Systematic Review and Meta-Analysis. Acta Neurochir (Wien) 2020, 162, 777–784. [Google Scholar] [CrossRef]
- Joyce, E.; Bounajem, M.T.; Scoville, J.; Thomas, A.J.; Ogilvy, C.S.; Riina, H.A.; Tanweer, O.; Levy, E.I.; Spiotta, A.M.; Gross, B.A.; et al. Middle Meningeal Artery Embolization Treatment of Nonacute Subdural Hematomas in the Elderly: A Multiinstitutional Experience of 151 Cases. Neurosurg Focus 2020, 49, E5. [Google Scholar] [CrossRef]
- Tudor, T.; Capone, S.; Vivanco-Suarez, J.; Salem, M.M.; Sioutas, G.S.; Tonetti, D.A.; Heiferman, D.M.; Kan, P.; Jankowitz, B.T.; Burkhardt, J.; et al. Middle Meningeal Artery Embolization for Chronic Subdural Hematoma: A Review of Established and Emerging Embolic Agents. Stroke: Vascular and Interventional Neurology 2024, 4. [Google Scholar] [CrossRef]
- Sioutas, G.S.; Vivanco-Suarez, J.; Shekhtman, O.; Matache, I.-M.; Salem, M.M.; Burkhardt, J.-K.; Srinivasan, V.M.; Jankowitz, B.T. Liquid Embolic Agents for Middle Meningeal Artery Embolization in Chronic Subdural Hematoma: Institutional Experience with Systematic Review and Meta-Analysis. Interv Neuroradiol 2023, 15910199231183132. [Google Scholar] [CrossRef] [PubMed]
- Ku, J.C.; Dmytriw, A.A.; Essibayi, M.A.; Banihashemi, M.A.; Vranic, J.E.; Ghozy, S.; Altschul, D.; Regenhardt, R.W.; Stapleton, C.J.; Yang, V.X.D.; et al. Embolic Agent Choice in Middle Meningeal Artery Embolization as Primary or Adjunct Treatment for Chronic Subdural Hematoma: A Systematic Review and Meta-Analysis. AJNR Am J Neuroradiol 2023, 44, 297–302. [Google Scholar] [CrossRef] [PubMed]
- Mowla, A.; Abdollahifard, S.; Farrokhi, A.; Yousefi, O.; Valibeygi, A.; Azami, P. Middle Meningeal Artery Embolization with Liquid Embolic Agents for Chronic Subdural Hematoma: A Systematic Review and Meta-Analysis. Journal of Vascular and Interventional Radiology 2023, 34, 1493–1500.e7. [Google Scholar] [CrossRef] [PubMed]
- Omura, Y.; Ishiguro, T. Middle Meningeal Artery Embolization for Chronic Subdural Hematoma: A Systematic Review. Front Neurol 2023, 14, 1259647. [Google Scholar] [CrossRef]
- Levitt, M.R.; Hirsch, J.A.; Chen, M. Middle Meningeal Artery Embolization for Chronic Subdural Hematoma: An Effective Treatment with a Bright Future. J Neurointerv Surg 2024, 16, 329–330. [Google Scholar] [CrossRef]
- Edlmann, E.; Holl, D.C.; Lingsma, H.F.; Bartek, J.; Bartley, A.; Duerinck, J.; Jensen, T.S.R.; Soleman, J.; Shanbhag, N.C.; Devi, B.I.; et al. Systematic Review of Current Randomised Control Trials in Chronic Subdural Haematoma and Proposal for an International Collaborative Approach. Acta Neurochir (Wien) 2020, 162, 763–776. [Google Scholar] [CrossRef]
- Adusumilli, G.; Ghozy, S.; Kallmes, K.M.; Hardy, N.; Tarchand, R.; Zinn, C.; Lamar, D.; Singeltary, E.; Siegel, L.; Kallmes, D.F.; et al. Common Data Elements Reported on Middle Meningeal Artery Embolization in Chronic Subdural Hematoma: An Interactive Systematic Review of Recent Trials. J Neurointerv Surg 2022, 14, 1027–1032. [Google Scholar] [CrossRef]
- Vollherbst, D.F.; Chapot, R.; Bendszus, M.; Möhlenbruch, M.A. Glue, Onyx, Squid or PHIL? Liquid Embolic Agents for the Embolization of Cerebral Arteriovenous Malformations and Dural Arteriovenous Fistulas. Clin Neuroradiol 2022, 32, 25–38. [Google Scholar] [CrossRef]
- Ma, L.; Hoz, S.S.; Doheim, M.F.; Fadhil, A.; Sultany, A.; Al-Bayati, A.R.; Nogueira, R.G.; Lang, M.J.; Gross, B.A. Impact of Embolisate Penetration, Type, and Technique on Results After Standalone Middle Meningeal Artery Embolization for Chronic Subdural Hematoma. Neurosurgery 2024. [Google Scholar] [CrossRef]
- Kerber, C.W.; Newton, T.H. The Macro and Microvasculature of the Dura Mater. Neuroradiology 1973, 6, 175–179. [Google Scholar] [CrossRef]
- Saeed Kilani, M.; Zehtabi, F.; Lerouge, S.; Soulez, G.; Bartoli, J.M.; Vidal, V.; Badran, M.F. New Alcohol and Onyx Mixture for Embolization: Feasibility and Proof of Concept in Both In Vitro and In Vivo Models. Cardiovasc Intervent Radiol 2017, 40, 735–743. [Google Scholar] [CrossRef] [PubMed]
- Kuianova, I.; Chupakhin, A.; Besov, A.; Gorbatykh, A.; Kislitsin, D.; Orlov, K.; Parshin, D. Rheological Properties of Non-Adhesive Embolizing Compounds—The Key to Fine-Tuning Embolization Process-Modeling in Endovascular Surgery. Polymers (Basel) 2023, 15, 1060. [Google Scholar] [CrossRef] [PubMed]
- Siekmann, R. Basics and Principles in the Application of Onyx LD Liquid Embolic System in the Endovascular Treatment of Cerebral Arteriovenous Malformations. Interventional Neuroradiology 2005, 11, 131–140. [Google Scholar] [CrossRef] [PubMed]
- Vollherbst, D.F.; Chapot, R.; Bendszus, M.; Möhlenbruch, M.A. Glue, Onyx, Squid or PHIL? Liquid Embolic Agents for the Embolization of Cerebral Arteriovenous Malformations and Dural Arteriovenous Fistulas. Clin Neuroradiol 2021. [Google Scholar] [CrossRef]
- Reshetnyak, D.V.; Zhavoronok, E.S.; Legon’kova, O.A.; Ogannisyan, A.S.; Panov, A.V.; Kedik, S.A. Modern Liquid Embolization Agents Based on Polymers: Composition, Characteristics, and Areas of Application. Review. Polymer Science - Series D 2022, 15, 64–70. [Google Scholar] [CrossRef]
- Lozupone, E.; Bracco, S.; Trombatore, P.; Milonia, L.; D’Argento, F.; Alexandre, A.; Valente, I.; Semeraro, V.; Cioni, S.; Pedicelli, A. Endovascular Treatment of Cerebral Dural Arteriovenous Fistulas with SQUID 12. Interventional Neuroradiology 2020, 26, 651–657. [Google Scholar] [CrossRef]
- FitzGerald, P.F.; Butts, M.D.; Roberts, J.C.; Colborn, R.E.; Torres, A.S.; Lee, B.D.; Yeh, B.M.; Bonitatibus, P.J. A Proposed Computed Tomography Contrast Agent Using Carboxybetaine Zwitterionic Tantalum Oxide Nanoparticles: Imaging, Biological, and Physicochemical Performance. Invest Radiol 2016, 51, 786–796. [Google Scholar] [CrossRef]
- Sungail, C.; Abid, A. Spherical Tantalum Feed Powder for Metal Additive Manufacturing. Metal Powder Report 2018, 73, 316–318. [Google Scholar] [CrossRef]
- Sungail, C.; Abid, A.D. Additive Manufacturing of Tantalum – A Study of Chemical and Physical Properties of Printed Tantalum. Metal Powder Report 2020, 75, 28–33. [Google Scholar] [CrossRef]
- Schmitt, N.; Floca, R.O.; Paech, D.; El Shafie, R.A.; Seker, F.; Bendszus, M.; Möhlenbruch, M.A.; Vollherbst, D.F. Imaging Artifacts of Liquid Embolic Agents on Conventional CT in an Experimental in Vitro Model. AJNR Am J Neuroradiol 2021, 42, 126–131. [Google Scholar] [CrossRef]
- Pop, R.; Mertz, L.; Ilyes, A.; Mihoc, D.; Richter, J.S.; Manisor, M.; Kremer, S.; Beaujeux, R. Beam Hardening Artifacts of Liquid Embolic Agents: Comparison between Squid and Onyx. J Neurointerv Surg 2019, 11, 706–709. [Google Scholar] [CrossRef] [PubMed]
- Onyx® Liquid Embolic System (INSTRUCTIONS FOR USE). Available online: https://www.accessdata.fda.gov/cdrh_docs/pdf3/P030004c.pdf (accessed on 20 August 2024).
- Lord, J.; Britton, H.; Spain, S.G.; Lewis, A.L. Advancements in the Development on New Liquid Embolic Agents for Use in Therapeutic Embolisation. J Mater Chem B 2020, 8, 8207–8218. [Google Scholar] [CrossRef] [PubMed]
- Panagiotopoulos, V.; Gizewski, E.; Asgari, S.; Regel, J.; Forsting, M.; Wanke, I. Embolization of Intracranial Arteriovenous Malformations with Ethylene-Vinyl Alcohol Copolymer (Onyx). AJNR Am J Neuroradiol 2009, 30, 99–106. [Google Scholar] [CrossRef] [PubMed]
- Reshetnyak, D.V.; Zhavoronok, E.S.; Legon’kova, O.A.; Ogannisyan, A.S.; Panov, A.V.; Kedik, S.A. Modern Liquid Embolization Agents Based on Polymers: Composition, Characteristics, and Areas of Application. Review. Polymer Science, Series D 2022, 15, 64–70. [Google Scholar] [CrossRef]
- SQUID Liquid Embolic Agent (User Manual). Available online: https://docs.nevacert.ru/files/med_reestr_v2/23334_instruction.pdf (accessed on 21 August 2024).
- Juan, Y.-H.; Lin, Y.-C.; Sheng, T.-W.; Cheung, Y.-C.; Ng, S.-H.; Yu, C.-W.; Wong, H.-F. Application of Onyx for Renal Arteriovenous Malformation With First Case Report of a Renal Hyperdense Striation Sign: A CARE-Compliant Article. Medicine 2015, 94, e1658. [Google Scholar] [CrossRef]
- Onyx Liquid Embolic System (LES) Appendix for the Instruction for Use. Available online: https://docs.nevacert.ru/files/med_reestr_v2/39314_instruction.pdf (accessed on 21 August 2024).
- Maes, C.; Yuki Junior, G.M.; Teniers, C.; Luyten, W.; Herremans, G.; Peeters, R.; Samyn, P.; Carleer, R.; Buntinx, M. Ethylene Vinyl Alcohol Copolymer (EVOH) as a Functional Barrier against Surrogate Components Migrating from Paperboard. J Chem 2019, 2019, 1–7. [Google Scholar] [CrossRef]
- Bonasia, S.; Smajda, S.; Ciccio, G.; Robert, T. Middle Meningeal Artery: Anatomy and Variations. American Journal of Neuroradiology 2020, 41, 1777–1785. [Google Scholar] [CrossRef]
- Lee, Y.M.; Mattay, R.R.; Haddad, A.F.; Rinaldo, L.; Savastano, L. Middle Meningeal Artery Embolization with Polyvinyl Alcohol Particles in a Patient with Ophthalmic Artery Origin from Middle Meningeal Artery: Case Report and Technical Note. Interventional Neuroradiology 2023. [Google Scholar] [CrossRef]
- Sant’Anna, M.A.F.; Luciano, L.L.; Chaves, P.H.S.; Santos, L.A. dos; Moreira, R.G.; Peixoto, R.; Barcellos, R.; Reis, G.A.; Pereira, C.U.; Rabelo, N.N. Anatomy of the Middle Meningeal Artery. Arquivos Brasileiros de Neurocirurgia: Brazilian Neurosurgery 2021, 40, e339–e348. [Google Scholar] [CrossRef]
- Yu, J.; Guo, Y.; Xu, B.; Xu, K. Clinical Importance of the Middle Meningeal Artery: A Review of the Literature. Int J Med Sci 2016, 13, 790–799. [Google Scholar] [CrossRef]
- Martínez, J.L.; Domingo, R.A.; Sattur, M.; Porto, G.; Rivas, G.A.; Al Kasab, S.; Spiotta, A. The Middle Meningeal Artery: Branches, Dangerous Anastomoses, and Implications in Neurosurgery and Neuroendovascular Surgery. Operative Neurosurgery 2022, 22, 1–13. [Google Scholar] [CrossRef] [PubMed]
- Hildebrandt, N.; Stienen, M.N.; Patzer, J.; Surbeck, W. Neurosurgical Contributions of the Swiss Surgeon, Rudolf Ulrich Krönlein - A Further Pioneer in Swiss Neurosurgery. Acta Neurochir (Wien) 2012, 154, 1923–1933. [Google Scholar] [CrossRef] [PubMed]
- Toida, N. Über Die Endokranischen Furchen Der Arteria Meningea Media Bei Den Chinesen. Journal of Oriental Medicine 1934, 13–15. [Google Scholar]
- Akiba, T. Über Die Endokranischen Furchen Der Arteria Meningea Media Bei Japanern. Z Morphol Anthropol 1925, 23, 343–360. [Google Scholar]
- Giuffrida-Ruggieri, V. Uber Die Endocranischen Furchen Der Arteria Meningea Media Beim Menschen. Zeitschr. f. Morph. u. Anthrop 1913, 15, 401–4013. [Google Scholar]
- Adachi, B. Das Arteriensystem Der Japaner Bd. I. A. Pulmonalis, Aorta. Arcus Volaris Profundus.; Kaiserlich-japanische Universität zu Kyoto, in kommission bei “Maruzen Co.”: Kyoto and Tokyo, 1928. [Google Scholar]
- Rothman, D. The Endocranial Course of the Middle Meningeal Artery in American Whites and American Negroes. Am J Phys Anthropol 1937, 22, 425–435. [Google Scholar] [CrossRef]
- Shotar, E.; Premat, K.; Lenck, S.; Degos, V.; Marijon, P.; Pouvelle, A.; Pouliquen, G.; Mouyal, S.; Abi Jaoude, S.; Sourour, N.-A.; et al. Angiographic Anatomy of the Middle Meningeal Artery in Relation to Chronic Subdural Hematoma Embolization. Clin Neuroradiol 2021. [Google Scholar] [CrossRef]
- Melnikova, G.; Kuznetsova, T.; Lapitskaya, V.; Petrovskaya, A.; Chizhik, S.; Zykova, A.; Safonov, V.; Aizikovich, S.; Sadyrin, E.; Sun, W.; et al. Nanomechanical and Nanotribological Properties of Nanostructured Coatings of Tantalum and Its Compounds on Steel Substrates. Nanomaterials 2021, 11, 2407. [Google Scholar] [CrossRef]
- Shapiro, M.; Walker, M.; Carroll, K.T.; Levitt, M.R.; Raz, E.; Nossek, E.; Delavari, N.; Mir, O.; Nelson, P.K. Neuroanatomy of Cranial Dural Vessels: Implications for Subdural Hematoma Embolization. J Neurointerv Surg 2021, 13, 471–477. [Google Scholar] [CrossRef]
- Ellens, N.R.; Schartz, D.; Kohli, G.; Rahmani, R.; Akkipeddi, S.M.K.; Mattingly, T.K.; Bhalla, T.; Bender, M.T. Safety and Efficacy Comparison of Embolic Agents for Middle Meningeal Artery Embolization for Chronic Subdural Hematoma. J Cerebrovasc Endovasc Neurosurg 2023. [Google Scholar] [CrossRef]
- Kulcsár, Z.; Karol, A.; Kronen, P.W.; Svende, P.; Klein, K.; Jordan, O.; Wanke, I. A Novel, Non-Adhesive, Precipitating Liquid Embolic Implant with Intrinsic Radiopacity: Feasibility and Safety Animal Study. Eur Radiol 2017, 27, 1248–1256. [Google Scholar] [CrossRef] [PubMed]









| Embolic agent | Polymer | polymer concentration (%) | Viscosity at 40°C, cSt |
Contrast agent | tantalum concentration (%) | Tantalum granule size (µm) | Minimal vessel diameter (µm) |
|---|---|---|---|---|---|---|---|
| Onyx 18 | EVOH (EVAL) [24,32,33,34] | 6.0 [24,35] | 18 [24,35] | Tantalum grain [32] | 35 [36] | 0.7 -22 [37] | 150 [38] |
| Onyx 20 | 6.5 [24,35] | 20 [24,35] | 35 [36] |
0.7 -22 [37] | 150 [38] | ||
| Onyx 34 | 8.0 [24,35] | 34 [24,35] | 35 [36] |
0.7 -22 [37] | 150 [38] | ||
| Squid 12 | EVOH (ЕVASIN) [24,32,33,36] | 4.0 [35,36] | 12 [35,36] | “micronized” tantalum grain [36] | 30 [36] | <1 [36] | no data |
| Squid 12 LD | 4.0 [35,36] | 12 [35,36] | 20 [36] | <1 [36] | no data | ||
| Squid 18 | 5.3 [35,36] | 18 [35,36] | 30 [36] | <1 [36] | no data | ||
| Squid 18 LD | 5.3 [35,36] | 18 [35,36] | 20 [36] | <1 [36] | no data |
| Element | Line type | Weight % | Sigma Weight % | Atom. % |
|---|---|---|---|---|
| Spectrum 1 (tantalum powder in Onyx 18) | ||||
| Ta | L-series | 100.0 | 0.00 | 100.0 |
| Spectrum 2 (tantalum powder in Squid 18). | ||||
| С | K-series | 26.01 | 2.54 | 70.52 |
| O | K-series | 8.71 | 1,41 | 17.72 |
| Ta | L-series | 65.29 | 2.61 | 11.75 |
| Variables | NAGLEMs | p | |
|---|---|---|---|
| ONYX 18 (n=8) |
SQUID 18 (n=8) |
||
| Patient age (years), M (SD) | 64.75 (12.98) | 59.63 (15.89) | 0.492 |
| Sex female/male, abs. (%) |
2 (25.0%)/6 (75.0%) |
3 (37.5%)/5 (62.5%) |
1.000 |
| CSDH location, abs. (%) | |||
| Bilateral | 3 (37,5 %) | 4 (50.0%) | 0.842 |
| Left unilateral | 3 (37,5 %) | 2 (25.0%) | |
| Right unilateral | 2 (25,0 %) | 2 (25.0%) | |
| Previous surgery evacuation | 3 (37,5 %) | 2 (25.0%) | 1.000 |
| Causative factor, abs. (%) | |||
| anticoagulant therapy | 2 (25.0%) | 1 (12.5%) | 1.000 |
| trauma | 6 (75.0%) | 7 (87.5%) | |
| mRS at the time of admission, M (SD) | 1.38 (1.19) | 1.25 (0.71) | 0.802 |
| Midline shift at the time of admission (mm), M (SD) | 3.50 (3.59) | 4.38 (4.06) | 0.655 |
| Maximum thickness of the left ChSDH (mm), M (SD) | 15.17 (7.99) | 18.08 (6.67) | 0.508 |
| Maximum thickness of the right ChSDH (mm), M (SD) | 16.43 (8.46) | 18.90 (7.11) | 0.565 |
| Side of MMA embolization, abs. (%) | |||
| Bilateral | 5 (62.5%) | 4 (50.0%) | 0.801 |
| Left side | 1 (12.5%) | 2 (25.0%) | |
| Right side | 2 (25.0%) | 2 (25.0%) | |
| Days of total ChSDH resolution (days), Me [IQR] | 195.00 [183.75; 217.00] | 191.00 [154.25; 199.50] | 0.343 |
| Variables | NAGLEMs | p | |
|---|---|---|---|
| ONYX 18 (n=8) |
SQUID 18 (n=8) |
||
| Penetration levels NAGLEMs | |||
| I | 1 (9,1%) | 0 (0,0%) | 0,009 |
| II | 7 (63,6%) | 1 (8,3%) | |
| III | 3 (27,3%) | 6 (50,0%) | |
| IV | 0 (0,0%) | 5 (41,7%) | |
| Level of microcatheter position in MMA | |||
| I | 3 (27.3%) | 1 (8.3%) | 0.462 |
| II | 7 (63.6%) | 9 (75.0%) | |
| III | 1 (9.1%) | 2 (16.7%) | |
| Microcatheter, abs. (%) | |||
| Headway 17 | 9 (81.8%) | 9 (75.0%) | 1.000 |
| Headway 21 | 2 (18.2%) | 3 (25.0%) | |
| Penetration into the dural veins at the first push | 0 (0.0%) | 3 (37.5%) | 0.200 |
| Penetration into the dural veins at the end of embolization | 3 (37.5%) | 8 (100.0%) | 0.026* |
| NAGLEMs extravasation | 7 (87.5%) | 2 (25.0%) | 0.041* |
| Average time of the appearance of extravasation from the beginning of embolization NAGLEMs (min) Me [IQR] |
5.30 [5.00; 6.25] | 11.20 [9.20; 12.30] | 0.012* |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).